Clovis Oncology, Inc. Other Operating Activities, Cash Flow Statement
Clovis Oncology, Inc. reported Other Operating Activities, Cash Flow Statement of $1.12 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherOperatingActivitiesCashFlowStatement · last filed 2022-11-09
- Clovis Oncology, Inc. other operating activities, cash flow statement for the quarter ending 2022-09-30 was $369.00K.
- Clovis Oncology, Inc. other operating activities, cash flow statement for the quarter ending 2022-06-30 was $383.00K, a 62.85% decline year-over-year.
- Clovis Oncology, Inc. other operating activities, cash flow statement for the quarter ending 2022-03-31 was $368.00K, a 58.04% decline year-over-year.
- Clovis Oncology, Inc. other operating activities, cash flow statement for the quarter ending 2021-12-31 was $517.00K.
- Clovis Oncology, Inc. other operating activities, cash flow statement for fiscal 2021 was $1.82M, a 434.41% increase from fiscal 2020.
- Clovis Oncology, Inc. other operating activities, cash flow statement for fiscal 2020 was $340.00K, a 57.71% decline from fiscal 2019.
- Clovis Oncology, Inc. other operating activities, cash flow statement for fiscal 2019 was $804.00K.
| Period end | Other Operating Activities, Cash Flow Statement 3 month | Other Operating Activities, Cash Flow Statement 6 month | Other Operating Activities, Cash Flow Statement 9 month | Other Operating Activities, Cash Flow Statement 12 month |
|---|---|---|---|---|
| 2022-09-30 | $369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $752.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.12M 10-Q · filed 2022-11-09 | $1.64M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $383.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $751.00K 10-Q · filed 2022-08-08 | $1.27M derived: sum of 3 quarters · filed 2022-08-08 | $660.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $368.00K 10-Q · filed 2022-05-05 | $885.00K derived: sum of 2 quarters · filed 2022-05-05 | $277.00K derived: sum of 3 quarters · filed 2022-11-09 | $1.31M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $517.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$91.00K derived: sum of 2 quarters · filed 2022-11-09 | $940.00K derived: sum of 3 quarters · filed 2022-11-09 | $1.82M 10-K · filed 2022-02-24 |
| 2021-09-30 | -$608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $423.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.30M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.91M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $877.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $340.00K 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $804.00K 10-K · filed 2022-02-24 |